지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2019.1
- 수록면
- 37 - 39 (3page)
이용수
초록· 키워드
오류제보하기
등록된 정보가 없습니다.
목차
등록된 정보가 없습니다.
참고문헌 (15)
참고문헌 신청
de Franchis R / 2005 / Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension / J Hepatol 43:167~176
Bruix J / 2011 / Management of hepatocellular carcinoma : an update / Hepatology 53:1020~1022
European Association For The Study Of The Liver / 2012 / EASL-EORTC clinical practice guidelines : management of hepatocellular carcinoma / J Hepatol 56:908~943
Anthony PP / 1978 / The morphology of cirrhosis. Recommendations on definition, nomenclature, and classification by a working group sponsored by the World Health Organization / J Clin Pathol 31:395~414
Soresi M / 2014 / Non invasive tools for the diagnosis of liver cirrhosis / World J Gastroenterol 20:18131~18150
Bruix J / 2011 / Management of hepatocellular carcinoma : an update / Hepatology 53:1020~1022
European Association For The Study Of The Liver / 2012 / EASL-EORTC clinical practice guidelines : management of hepatocellular carcinoma / J Hepatol 56:908~943
Anthony PP / 1978 / The morphology of cirrhosis. Recommendations on definition, nomenclature, and classification by a working group sponsored by the World Health Organization / J Clin Pathol 31:395~414
Soresi M / 2014 / Non invasive tools for the diagnosis of liver cirrhosis / World J Gastroenterol 20:18131~18150
함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Non-alcoholic Fatty Liver Disease (NAFLD) and Significant Hepatic Fibrosis Defined by Non-invasive Assessment in Patients with Type 2 Diabetes
Asian Pacific journal of cancer prevention : APJCP
2015 .01
-
Evaluation of disease severity using multimodal MR imaging in hepatic fibrosis animal model
한국실험동물학회 학술발표대회 논문집
2019 .07
-
Renal Tubular Damage Marker, Urinary N-acetyl-β-D-Glucosaminidase, as a Predictive Marker of Hepatic Fibrosis in Type 2 Diabetes Mellitus
Diabetes and Metabolism Journal
2022 .01
-
Serologic Biomarkers for Hepatic Fibrosis in Obese Children with Nonalcoholic Steatohepatitis
Pediatric Gastroenterology, Hepatology & Nutrition
2024 .07
-
Non-invasive biomarkers of liver fibrosis in non-alcoholic fatty liver disease
Clinical and Molecular Hepatology
2023 .04
-
How does hepatic steatosis affect the outcome of patients with chronic hepatitis B?
Clinical and Molecular Hepatology
2019 .01
-
Usefulness of 2D shear wave elastography for the evaluation of hepatic fibrosis and treatment response in patients with autoimmune hepatitis
ULTRASONOGRAPHY
2022 .10
-
Noninvasive serum biomarkers for liver fibrosis in NAFLD: current and future
Clinical and Molecular Hepatology
2023 .02
-
Hepatic Steatosis but Not Fibrosis Is Independently Associated with Poor Outcomes in Patients with Inflammatory Bowel Disease
Gut and Liver
2024 .03
-
A comparative study of artificial intelligence analysis for diagnosis of liver fibrosis in rats
한국실험동물학회 학술발표대회 논문집
2022 .07
-
Hepatic Fibrosis and Cancer: The Silent Threats of Metabolic Syndrome
Diabetes and Metabolism Journal
2024 .03
-
An application of convolution neural network for analyzing hepatic fibrosis in mouse
한국실험동물학회 학술발표대회 논문집
2022 .01
-
Quantitative Hepatitis B Surface Antigen, the Trustworthy Biomarker for Functional Cure of Chronic Hepatitis B
Gut and Liver
2023 .03
-
Noninvasive Assessment of Advanced Fibrosis Based on Hepatic Volume in Patients with Nonalcoholic Fatty Liver Disease
Gut and Liver
2017 .01
-
Exogenous Natural Glycoprotein Multiple Mechanisms of Anti-tumor Activity
Asian Pacific journal of cancer prevention : APJCP
2015 .01
-
Current role of transient elastography in the management of chronic hepatitis B patients
ULTRASONOGRAPHY
2017 .01
-
Hepatic Fibrosis and Steatosis in Metabolic Syndrome
Journal of Obesity & Metabolic Syndrome
2022 .03
-
Direct-acting antivirals-based therapy decreases hepatic fibrosis serum biomarker microfibrillarassociated protein 4 in hepatitis C patients
Clinical and Molecular Hepatology
2019 .01
-
Negligible risk of hepatocellular carcinoma in chronic hepatitis B patients in immune-tolerant phase: Myth or fact
Clinical and Molecular Hepatology
2021 .01
-
Evaluation of the histological scoring systems of autoimmune hepatitis: A significant step towards the optimization of clinical diagnosis
Clinical and Molecular Hepatology
2024 .04
이 논문의 저자 정보
최근 본 자료
댓글(0)
0